GO:0010469 regulation of signaling receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010469 (regulation of signaling receptor activity) describes any process that modulates the frequency, rate or extent of a signaling receptor activity, where receptor activity is the ability to bind an extracellular or intracellular messenger and initiate a change in cell activity.
• Regulation occurs at multiple levels: ligand availability, receptor expression, post-translational modifications, trafficking, and interaction with accessory proteins [2,6].
• Dysregulation of signaling receptor activity is implicated in cancer, metabolic disorders, cardiovascular aging, and neurological conditions [2,5,6].
• Key regulatory mechanisms include phosphorylation, ubiquitination, endosomal trafficking, and feedback loops involving Smad and ERK pathways [2,4].
• Exercise and metabolic cues can modulate receptor signaling via pathways such as PGC-1α/FNDC5/BDNF and lactate-mediated lactylation [1,7].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to dissect causal roles of receptor regulatory components [2,6].
Description
Regulation of signaling receptor activity (GO:0010469) is a fundamental biological process that controls how cells respond to extracellular and intracellular messengers. It encompasses any mechanism that adjusts the frequency, rate, or extent of receptor activity, thereby shaping signal transduction outcomes [2,6]. This regulation is critical for normal development, tissue homeostasis, and adaptive responses to environmental cues [1,5]. Dysregulation of receptor signaling underlies numerous pathologies, including cancer, metabolic diseases, and neurodegeneration [2,5,6]. Understanding the molecular players and regulatory circuits is therefore a major focus of biomedical research. This article integrates authoritative QuickGO data with verified PubMed literature to provide a research-grade overview of GO:0010469, covering its definition, mechanisms, key genes, disease links, and experimental models.
regulation of signaling receptor activity At A Glance
| GO ID | GO:0010469 |
|---|---|
| GO term | regulation of signaling receptor activity |
| Ontology | biological_process |
| Synonym | regulation of receptor activity; regulation of signalling receptor activity |
| Major function | Modulates the frequency, rate or extent of signaling receptor activity, thereby controlling cellular responses to extracellular and intracellular messengers. |
| Related processes | Signal transduction, receptor trafficking, post-translational modification, feedback regulation. |
| Key regulators | Ligands, kinases, phosphatases, ubiquitin ligases, accessory proteins, endosomal sorting complexes. |
| Disease relevance | Cancer, metabolic disorders, cardiovascular aging, neurological disorders. |
What Is GO:0010469?
GO:0010469, regulation of signaling receptor activity, is defined as any process that modulates the frequency, rate or extent of a signaling receptor activity. Receptor activity itself refers to the ability of a molecule to combine with an extracellular or intracellular messenger and initiate a change in cell activity. This term is a biological process and includes both positive and negative regulation of receptor function, such as changes in receptor abundance, affinity, or downstream signaling capacity [2,6].
Why Is regulation of signaling receptor activity Important in Cell Biology?
Regulation of signaling receptor activity is central to virtually all physiological processes, from embryonic development to immune responses and neuronal plasticity [2,6]. It ensures that cells respond appropriately to hormones, growth factors, and neurotransmitters, and its disruption can lead to uncontrolled proliferation, metabolic dysfunction, or neurodegeneration [2,5,6]. Moreover, therapeutic strategies often target receptor regulatory mechanisms, making this GO term highly relevant for drug discovery and precision medicine [2,4].
• Controls cellular responses to hormones, growth factors, and neurotransmitters [2,6].
• Essential for development, tissue homeostasis, and repair [1,5].
• Dysregulation is a hallmark of cancer, where receptor overactivation drives proliferation.
• Implicated in metabolic diseases such as diabetes and obesity.
• Plays a role in cardiovascular aging through endothelial signaling networks.
• Modulates neuronal function and neuroprotection via neurokine receptors.
• Influences immune cell survival and apoptosis during exercise.
• Targeted by many pharmacological agents, including kinase inhibitors and monoclonal antibodies [2,4].
• Provides mechanistic insights for CRISPR-based therapeutic editing [2,6].
• Key to understanding adaptive responses like exercise-induced signaling [1,7].
What Happens During regulation of signaling receptor activity?
Ligand availability and receptor binding
In simple terms: The amount of messenger molecule available and how well it binds to the receptor set the initial level of signaling.
Regulation begins with the availability of extracellular or intracellular messengers. Ligand concentration, affinity, and competition with antagonists modulate receptor occupancy and activation. For example, TGF-beta family ligands bind to type I and type II receptors, initiating Smad-dependent and Smad-independent signaling. Neurokine receptors are regulated by ligand availability and receptor trafficking.
Post-translational modifications of receptors
In simple terms: Chemical tags added to receptors can turn their signaling up or down.
Phosphorylation, ubiquitination, glycosylation, and other modifications directly alter receptor activity, stability, and interactions. TGF-beta receptors are phosphorylated and ubiquitinated, affecting their turnover and signaling output. Beta-adrenergic receptors undergo phosphorylation that influences their coupling to G proteins and downstream ERK activation.
Receptor trafficking and endosomal signaling
In simple terms: Receptors move inside the cell, where they can continue signaling from different locations.
Endocytosis, recycling, and degradation control the duration and location of receptor signaling. Non-canonical beta-adrenergic activation of ERK occurs at endosomes, highlighting the importance of spatial regulation. Neurokine receptor trafficking is a key determinant of signaling specificity and duration.
Feedback loops and cross-talk
In simple terms: Signaling pathways talk to each other and can shut themselves down to prevent overactivity.
Negative feedback loops, such as those involving Smad7 in TGF-beta signaling, and cross-talk with other pathways (e.g., MAPK, PI3K) fine-tune receptor activity. Exercise-induced signaling involves PGC-1α/FNDC5/BDNF and lactate-lactylation, demonstrating integration of metabolic and receptor pathways [1,7].
Regulation by accessory proteins and scaffolds
In simple terms: Helper proteins can bring receptors together with signaling molecules or keep them inactive.
Accessory proteins, scaffolds, and chaperones modulate receptor folding, localization, and activity. For instance, Smad anchor for receptor activation (SARA) facilitates TGF-beta receptor signaling. Endothelial NAD+-H2S signaling network involves accessory factors that regulate receptor activity during vascular aging.
Key Genes Involved in GO:0010469 regulation of signaling receptor activity
The following genes and proteins are key players in the regulation of signaling receptor activity, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TGFBR1 | Type I TGF-beta receptor; mediates Smad-dependent and independent signaling | Cancer, fibrosis, and developmental disorders |
| TGFBR2 | Type II TGF-beta receptor; binds ligands and activates TGFBR1 | Cancer and connective tissue diseases |
| SMAD2/3 | Downstream effectors of TGF-beta receptor signaling | Transcriptional regulation and cancer |
| SMAD7 | Negative feedback regulator of TGF-beta receptor signaling | Inflammatory and fibrotic diseases |
| ADRB2 | Beta-2 adrenergic receptor; regulates ERK via endosomal signaling | Cardiovascular and respiratory diseases |
| ADRB1 | Beta-1 adrenergic receptor; regulates clock genes in osteoblasts | Bone metabolism and circadian regulation |
| FNDC5 | Exercise-induced myokine; regulates BDNF signaling | Metabolic and neurological benefits of exercise |
| BDNF | Neurotrophin; regulates TrkB receptor activity | Neurodegeneration and mood disorders |
| PGC-1α | Transcriptional coactivator; regulates FNDC5 expression | Exercise adaptation and metabolism |
| NGF | Neurotrophin; regulates TrkA receptor activity | Neurokine signaling and neuronal survival |
| TrkA | NGF receptor; regulates neurokine signaling and trafficking | Neurodegeneration and pain |
| EGFR | Epidermal growth factor receptor; regulates proliferation | Cancer and targeted therapy |
| INSR | Insulin receptor; regulates glucose uptake | Diabetes and metabolic syndrome |
| LEPR | Leptin receptor; regulates energy balance | Obesity and metabolic disorders |
| HIF1A | Hypoxia-inducible factor; regulates receptor expression | Cancer and ischemia |
| CBS | Cystathionine beta-synthase; regulates H2S signaling | Vascular aging and endothelial function |
| eNOS | Endothelial nitric oxide synthase; regulates receptor-mediated vasodilation | Cardiovascular health |
How Is regulation of signaling receptor activity Regulated?
Regulation of signaling receptor activity is itself controlled by multiple layers of regulation. Transcriptional control determines receptor abundance, while post-transcriptional mechanisms such as microRNAs and RNA-binding proteins affect mRNA stability and translation [2,6]. Post-translational modifications, including phosphorylation and ubiquitination, rapidly adjust receptor activity [2,4]. Feedback loops, such as Smad7-mediated inhibition of TGF-beta receptors, prevent excessive signaling. Metabolic cues, including lactate and NAD+ levels, modulate receptor signaling networks [5,7]. Exercise-induced pathways involving PGC-1α/FNDC5/BDNF illustrate systemic regulation. Additionally, circadian regulators and adrenergic signaling in osteoblasts show tissue-specific control.
regulation of signaling receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TGFBR1 | Cancer, fibrosis | Knockout and point-mutation cell lines to dissect Smad-dependent vs independent signaling |
| ADRB2 | Cardiovascular disease, asthma | Knock-in of phosphorylation-deficient mutants to study endosomal ERK activation |
| FNDC5 | Metabolic disorders, neurodegeneration | Overexpression and knockout models to assess BDNF regulation |
| CBS | Vascular aging | Knockout and knock-in models to restore H2S signaling |
| TrkA | Neurodegeneration, pain | Knockout and tagged knock-in for trafficking studies |
Cancer
Dysregulated signaling receptor activity is a hallmark of cancer. Overactivation of TGF-beta receptors promotes tumor progression and metastasis through Smad-dependent and independent pathways. EGFR and other receptor tyrosine kinases drive proliferation and survival, making them prime therapeutic targets. Mutations in receptor regulatory components can lead to constitutive activation, underscoring the need for precise CRISPR models [2,6].
Metabolic disorders
Altered regulation of insulin and leptin receptor activity contributes to insulin resistance and obesity. Exercise-induced lactate-lactylation and PGC-1α/FNDC5/BDNF pathways improve metabolic health by modulating receptor signaling [1,7]. Targeting these pathways could offer therapeutic benefits for diabetes and metabolic syndrome.
Cardiovascular aging
Impairment of endothelial NAD+-H2S signaling network leads to reversible vascular aging. This network regulates receptor activity and downstream vasoprotective effects. Restoring this signaling may reverse age-related vascular dysfunction.
Neurological disorders
Neurokine receptor signaling and trafficking are critical for neuronal survival and function. Dysregulation of NGF/TrkA signaling is implicated in neurodegeneration and chronic pain. BDNF signaling, regulated by exercise-induced FNDC5, supports cognitive health and mood regulation.
From regulation of signaling receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene regulate receptor activity? | CRISPR knockout in cell lines (e.g., HEK293, HeLa) followed by signaling assays |
| How does a specific phosphorylation site affect receptor function? | Point mutation (e.g., phospho-deficient or phospho-mimetic) via CRISPR knock-in |
| What is the effect of a disease-associated mutation? | Knock-in of the mutation in isogenic cell lines |
| Where and when is the receptor expressed? | Tagged knock-in (e.g., GFP, HA) for imaging and proteomics |
| Does overexpression of a regulator enhance signaling? | Overexpression via lentiviral or CRISPR activation |
| Which genes modulate receptor activity in a genome-wide manner? | CRISPR library screening with signaling readouts [2,6] |
How to Study the regulation of signaling receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Loss-of-function effects on receptor activity | Identify novel regulators of signaling |
| Phosphoproteomics | Changes in phosphorylation sites | Map receptor modification dynamics |
| Live-cell imaging | Receptor localization and trafficking | Study endosomal signaling [4,6] |
| RNA-seq | Transcriptional changes | Analyze feedback and cross-talk [1,7] |
| Proximity labeling (BioID) | Protein-protein interactions | Discover receptor complexes |
| Flow cytometry | Surface receptor levels | Quantify receptor abundance |
| Western blot | Protein expression and phosphorylation | Validate signaling changes |
| CRISPR activation (CRISPRa) | Gain-of-function effects | Overexpress regulators |
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify regulators of signaling receptor activity. These screens use reporter systems or phenotypic readouts to uncover genes that modulate receptor function [2,6].
Phosphoproteomics and proteomics
Mass spectrometry-based phosphoproteomics quantifies changes in receptor phosphorylation and downstream signaling. Proteomics can reveal interaction partners and post-translational modifications that regulate receptor activity [2,4].
Live-cell imaging and trafficking assays
Fluorescently tagged receptors and endosomal markers allow real-time visualization of receptor internalization, recycling, and signaling from specific compartments [4,6].
Transcriptomics and pathway analysis
RNA-seq and bioinformatics pathway analysis identify transcriptional changes and feedback loops that regulate receptor activity. This is particularly useful for understanding systemic effects like exercise-induced signaling [1,7].
How CRISPR Can Be Used to Study GO:0010469 regulation of signaling receptor activity
Knockout
CRISPR knockout is used to completely ablate a gene to determine its necessity in regulating signaling receptor activity. For example, knocking out TGFBR1 or TGFBR2 abolishes TGF-beta signaling, revealing their essential roles. Knockout of ADRB2 prevents beta-adrenergic ERK activation.
Point Mutation
Point mutations introduced by CRISPR (e.g., phospho-deficient or phospho-mimetic) allow precise dissection of regulatory sites. Mutating phosphorylation sites in ADRB2 can alter endosomal ERK signaling. Disease-associated mutations in TGFBR1 can be modeled to study constitutive activation.
Knock-in
Knock-in of tags (e.g., GFP, HA) or reporter genes enables visualization and quantification of receptor activity. Tagged neurokine receptors facilitate trafficking studies. Knock-in of disease mutations creates isogenic models for drug testing.
Overexpression
Overexpression via CRISPR activation or lentiviral delivery increases gene dosage to study gain-of-function effects. Overexpressing FNDC5 enhances BDNF signaling and metabolic benefits. Overexpression of Smad7 inhibits TGF-beta receptor signaling.
How EDITGENE Supports regulation of signaling receptor activity Research
Researchers studying regulation of signaling receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor regulation or is merely correlated. This requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant cell types. EDITGENE provides end-to-end CRISPR services to generate such models, enabling rigorous mechanistic studies and therapeutic target validation.
Contact EDITGENE today to design your custom CRISPR model for regulation of signaling receptor activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CGA Knockout HEK293 Cell Line | EDJ-KQ1760 | Human | 1081 | Details Get a Quote |
| CNRIP1 Knockout HEK293 Cell Line | EDJ-KQ8311 | Human | 25927 | Details Get a Quote |
| TAFA4 Knockout HEK293 Cell Line | EDJ-KQ11345 | Human | 151647 | Details Get a Quote |
| TAFA1 Knockout HEK293 Cell Line | EDJ-KQ11816 | Human | 407738 | Details Get a Quote |
| CGA Knockout HeLa Cell Line | EDJ-KQ21637 | Human | 1081 | Details Get a Quote |
| CNRIP1 Knockout HeLa Cell Line | EDJ-KQ34283 | Human | 25927 | Details Get a Quote |
| TAFA4 Knockout HeLa Cell Line | EDJ-KQ58691 | Human | 151647 | Details Get a Quote |
| TAFA1 Knockout HeLa Cell Line | EDJ-KQ60351 | Human | 407738 | Details Get a Quote |
| CGA Knockout A-549 Cell Line | EDJ-KQ61350 | Human | 1081 | Details Get a Quote |
| CNRIP1 Knockout A-549 Cell Line | EDJ-KQ64341 | Human | 25927 | Details Get a Quote |
| TAFA4 Knockout A-549 Cell Line | EDJ-KQ67174 | Human | 151647 | Details Get a Quote |
| TAFA1 Knockout A-549 Cell Line | EDJ-KQ68818 | Human | 407738 | Details Get a Quote |
| CGA Knockout HCT 116 Cell Line | EDJ-KQ69844 | Human | 1081 | Details Get a Quote |
| CNRIP1 Knockout HCT 116 Cell Line | EDJ-KQ72794 | Human | 25927 | Details Get a Quote |
| TAFA4 Knockout HCT 116 Cell Line | EDJ-KQ75576 | Human | 151647 | Details Get a Quote |
Displaying Records 1 To 15 Of 16 Records
Frequently Asked Questions About regulation of signaling receptor activity
What is GO:0010469?
GO:0010469 is the Gene Ontology term for regulation of signaling receptor activity, defined as any process that modulates the frequency, rate or extent of a signaling receptor activity [2,6].
What genes are involved in regulation of signaling receptor activity?
Key genes include TGFBR1, TGFBR2, SMAD2/3, SMAD7, ADRB2, ADRB1, FNDC5, BDNF, PGC-1α, NGF, TrkA, EGFR, INSR, LEPR, HIF1A, CBS, and eNOS [1,2,3,4,5,6,7].
How is signaling receptor activity regulated?
It is regulated at multiple levels: ligand availability, receptor expression, post-translational modifications, trafficking, and feedback loops [2,4,6].
What diseases are associated with dysregulated signaling receptor activity?
Cancer, metabolic disorders, cardiovascular aging, and neurological disorders are linked to dysregulation of receptor signaling [2,5,6].
What are the synonyms for GO:0010469?
Synonyms include regulation of receptor activity and regulation of signalling receptor activity.
How can CRISPR be used to study regulation of signaling receptor activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of gene function in receptor regulation [2,4,6].
What methods are used to study regulation of signaling receptor activity?
Common methods include CRISPR screens, phosphoproteomics, live-cell imaging, RNA-seq, and proximity labeling [2,4,6].
What is the role of TGF-beta signaling in receptor regulation?
TGF-beta ligands bind to type I and II receptors, activating Smad-dependent and independent pathways that regulate receptor activity.
How does exercise affect signaling receptor activity?
Exercise induces PGC-1α/FNDC5/BDNF signaling and lactate-lactylation, which modulate receptor activity and metabolic health [1,7].
What is the link between receptor regulation and vascular aging?
Impairment of endothelial NAD+-H2S signaling network leads to reversible vascular aging by dysregulating receptor activity.
Conclusion
Regulation of signaling receptor activity (GO:0010469) is a central biological process that controls how cells interpret and respond to their environment. Its dysregulation contributes to major human diseases, making it a prime target for therapeutic intervention. Advances in CRISPR-based models and multi-omics approaches are accelerating our understanding of the underlying mechanisms. EDITGENE provides comprehensive services to support research in this field, from knockout and knock-in cell models to library screening and bioinformatics.
References
- 1. Wrann CD et al.. 2013. Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway.. Cell Metab 18(5):649-59 PMID: 24120943
- 2. Derynck R et al.. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signalling.. Nature 425(6958):577-84 PMID: 14534577
- 3. Hirai T. 2018. Regulation of Clock Genes by Adrenergic Receptor Signaling in Osteoblasts.. Neurochem Res 43(1):129-135 PMID: 28752422
- 4. Kwon Y et al.. 2022. Non-canonical β-adrenergic activation of ERK at endosomes.. Nature 611(7934):173-179 PMID: 36289326
- 5. Das A et al.. 2018. Impairment of an Endothelial NAD(+)-H(2)S Signaling Network Is a Reversible Cause of Vascular Aging.. Cell 173(1):74-89.e20 PMID: 29570999
- 6. Nathanson NM. 2012. Regulation of neurokine receptor signaling and trafficking.. Neurochem Int 61(6):874-8 PMID: 22306348
- 7. Chen G et al.. 2025. Mechanisms for Regulatory Effects of Exercise on Metabolic Diseases from the Lactate-Lactylation Perspective.. Int J Mol Sci 26(8) PMID: 40331975
- 8. Krüger K et al.. 2014. Exercise-induced leukocyte apoptosis.. Exerc Immunol Rev 20:117-34 PMID: 24974724
